Abstract
The authors evaluate the role of intravitreal trimethoprim/sulfamethoxazole in the treatment of toxoplasma retinochoroiditis (TRC) in four patients. Intravitreal injection of trimethoprim/sulfamethoxazole 1.28 mg/0.08 mL with dexamethasone 400 ?g/0.1 mL was injected weekly or biweekly. After the initiation of treatment, a reduction in intraocular inflammation was observed clinically and on optical coherence tomography within 1 week. Three patients regained visual acuity of 20/20, and one patient improved to 20/40 with residual macular scarring. No evidence of retinal toxicity was noted on full-field electroretinogram. Intravitreal trimethoprim/sulfamethoxazole and dexamethasone combination may be an alternative treatment strategy in patients with TRC.
Original language | English (US) |
---|---|
Pages (from-to) | 137-140 |
Number of pages | 4 |
Journal | Ophthalmic Surgery Lasers and Imaging Retina |
Volume | 46 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2015 |
ASJC Scopus subject areas
- Surgery
- Ophthalmology